Thiogenesis Therapeutics
$0.3671
1
-$0.00-0% Tuesday 20:00
Statistics
Day High
0.3671
Day Low
0.3671
52W High
0.5834
52W Low
0.3565
Volume
2,500
Avg. Volume
206
Mkt Cap
25.69M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
24NovExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.04
-0.03
-0.02
-0.01
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-5.35MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. The company lead product candidate is TTI-0102, a prodrugs that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke-like episodes, leigh syndrome, pediatric metabolic dysfunction-associated steatohepatitis, and nephropathic cystinosis. The company is headquartered in Toronto, Canada.
Show more...
CEO
Country
Canada
ISIN
CA88410L1022
WKN
000A3D51F
Listings
0 Comments
Share your thoughts
FAQ
What is Thiogenesis Therapeutics stock price today?▼
The current price of TTIPF is $0.37 USD — it has decreased by -0% in the past 24 hours. Watch Thiogenesis Therapeutics stock price performance more closely on the chart.
What is Thiogenesis Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Thiogenesis Therapeutics stocks are traded under the ticker TTIPF.
Is Thiogenesis Therapeutics stock price growing?▼
TTIPF stock has risen by +0% compared to the previous week, the month change is a -12.57% fall, over the last year Thiogenesis Therapeutics has showed a -37.08% decrease.
What is Thiogenesis Therapeutics market cap?▼
Today Thiogenesis Therapeutics has the market capitalization of 25.69M
When is the next Thiogenesis Therapeutics earnings date?▼
Thiogenesis Therapeutics is going to release the next earnings report on November 24, 2026.
What were Thiogenesis Therapeutics earnings last quarter?▼
TTIPF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Thiogenesis Therapeutics revenue for the last year?▼
Thiogenesis Therapeutics revenue for the last year amounts to 0 USD.
What is Thiogenesis Therapeutics net income for the last year?▼
TTIPF net income for the last year is -5.35M USD.
In which sector is Thiogenesis Therapeutics located?▼
Thiogenesis Therapeutics operates in the Other sector.
When did Thiogenesis Therapeutics complete a stock split?▼
Thiogenesis Therapeutics has not had any recent stock splits.